Molecular Imaging and Biology ( IF 3.0 ) Pub Date : 2021-08-23 , DOI: 10.1007/s11307-021-01638-5 Camilo A Ruiz-Bedoya 1, 2, 3 , Filipa Mota 1, 2, 3 , Alvaro A Ordonez 1, 2, 3 , Catherine A Foss 1, 4 , Alok K Singh 3 , Monali Praharaj 5 , Farina J Mahmud 1, 2, 3 , Ali Ghayoor 6 , Kelly Flavahan 1, 2, 3 , Patricia De Jesus 1, 2, 3 , Melissa Bahr 1, 2, 3 , Santosh Dhakal 7 , Ruifeng Zhou 7 , Clarisse V Solis 8 , Kathleen R Mulka 8 , William R Bishai 3 , Andrew Pekosz 7, 8 , Joseph L Mankowski 8 , Jason Villano 8 , Sabra L Klein 7 , Sanjay K Jain 1, 2, 3, 4
Purpose
Molecular imaging has provided unparalleled opportunities to monitor disease processes, although tools for evaluating infection remain limited. Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mediated by lung injury that we sought to model. Activated macrophages/phagocytes have an important role in lung injury, which is responsible for subsequent respiratory failure and death. We performed pulmonary PET/CT with 124I-iodo-DPA-713, a low-molecular-weight pyrazolopyrimidine ligand selectively trapped by activated macrophages cells, to evaluate the local immune response in a hamster model of SARS-CoV-2 infection.
Procedures
Pulmonary 124I-iodo-DPA-713 PET/CT was performed in SARS-CoV-2-infected golden Syrian hamsters. CT images were quantified using a custom-built lung segmentation tool. Studies with DPA-713-IRDye680LT and a fluorescent analog of DPA-713 as well as histopathology and flow cytometry were performed on post-mortem tissues.
Results
Infected hamsters were imaged at the peak of inflammatory lung disease (7 days post-infection). Quantitative CT analysis was successful for all scans and demonstrated worse pulmonary disease in male versus female animals (P < 0.01). Increased 124I-iodo-DPA-713 PET activity co-localized with the pneumonic lesions. Additionally, higher pulmonary 124I-iodo-DPA-713 PET activity was noted in male versus female hamsters (P = 0.02). DPA-713-IRDye680LT also localized to the pneumonic lesions. Flow cytometry demonstrated a higher percentage of myeloid and CD11b + cells (macrophages, phagocytes) in male versus female lung tissues (P = 0.02).
Conclusion
124I-Iodo-DPA-713 accumulates within pneumonic lesions in a hamster model of SARS-CoV-2 infection. As a novel molecular imaging tool, 124I-Iodo-DPA-713 PET could serve as a noninvasive, clinically translatable approach to monitor SARS-CoV-2-associated pulmonary inflammation and expedite the development of novel therapeutics for COVID-19.
中文翻译:
SARS-CoV-2 感染仓鼠模型中的 124I-Iodo-DPA-713 正电子发射断层扫描
目的
分子成像为监测疾病过程提供了无与伦比的机会,尽管用于评估感染的工具仍然有限。由严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 引起的冠状病毒病 (COVID-19) 是由我们试图模拟的肺损伤介导的。活化的巨噬细胞/吞噬细胞在肺损伤中起重要作用,肺损伤是随后呼吸衰竭和死亡的原因。我们使用124 I-iodo-DPA-713(一种被活化的巨噬细胞选择性捕获的低分子量吡唑并嘧啶配体)进行了肺部 PET/CT,以评估 SARS-CoV-2 感染仓鼠模型中的局部免疫反应。
程序
在感染 SARS-CoV-2 的金色叙利亚仓鼠中进行肺124 I-iodo-DPA-713 PET/CT。使用定制的肺部分割工具对 CT 图像进行量化。对死后组织进行了 DPA-713-IRDye680LT 和 DPA-713 的荧光类似物以及组织病理学和流式细胞术的研究。
结果
感染的仓鼠在炎症性肺病的高峰期(感染后 7 天)成像。所有扫描的定量 CT 分析均成功,并证明雄性动物比雌性动物的肺部疾病更严重 ( P < 0.01)。增加的124 I-iodo-DPA-713 PET 活性与肺炎病变共定位。此外,雄性仓鼠与雌性仓鼠相比肺部124 I-iodo-DPA-713 PET 活性更高 ( P = 0.02)。DPA-713-IRDye680LT 也定位于肺病灶。流式细胞术显示男性肺组织与女性肺组织相比,骨髓和 CD11b + 细胞(巨噬细胞、吞噬细胞)的百分比更高 ( P = 0.02)。
结论
124 I-Iodo-DPA-713 在 SARS-CoV-2 感染的仓鼠模型中的肺炎病变内积聚。作为一种新型分子成像工具,124 I-Iodo-DPA-713 PET 可以作为一种无创、临床可转化的方法来监测 SARS-CoV-2 相关的肺部炎症,并加快 COVID-19 新型疗法的开发。